News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Itamar Medical Inc. Products Receive Brazilian ANVISA Certification to Enter South American Market


12/13/2011 7:07:54 AM

CAESAREA, Israel--(BUSINESS WIRE)--Itamar Medical, the world's leading developer of non-invasive technology for early detection of cardiovascular disease and home testing of obstructive sleep apnea, continues to penetrate new markets and has announced a breakthrough in South America by receiving ANVISA certification. The flagship products, WatchPAT and EndoPAT, may now be imported and sold freely to the clinical market of South America.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES